CLOs on the Move

ILiAD Biotechnologies

www.iliadbio.com

 
ILiAD Biotechnologies, LLC manufactures vaccines for the prevention and treatment of disease caused by Bordetella Pertussis.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.iliadbio.com
  • 230 East 15th Street Suite 1-A
    New York, NY USA 10003
  • Phone: 954.336.0777

Executives

Name Title Contact Details

Similar Companies

Neuraptive Therapeutics

Neuraptive is bringing novel therapeutic technology for the acute surgical repair of injured peripheral nerves.

Ocugen

Ocugen Inc.is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.

Nortern Lipids

Nortern Lipids is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Thrasos Therapeutics

Thrasos is a private, clinical-stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. The company's lead compound, THR-184 is currently being evaluated in a Phase 2 clinical study for the prevention of AKI in patients undergoing cardiac surgery. Thrasos is also developing compounds for diabetic nephropathy, a major cause of chronic kidney disease

Infomed

Infomed is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.